ALEMTUZUMAB FOR RELAPSING AND REFRACTORY PRIMARY SYSTEMIC VASCULITIS - A TRIAL OF EFFICACY AND SAFETY (ALEVIATE): A RANDOMISED OPEN-LABEL PHASE II CLINICAL TRIAL

被引：0
|
作者：
Gopaluni, Seerapani [1 ]
Goymer, Donna [2 ]
McClure, Mark [1 ]
Cahill, Hugh [2 ]
Broadhurst, Elizabeth [2 ]
Smith, Rona [1 ]
Jayne, David [1 ]
机构：
[1] Univ Cambridge, Cambridge, England
[2] Cambridge Univ Hosp NHS Trust, Cambridge, England
来源：
RHEUMATOLOGY | 2019年 / 58卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
302
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Mebendazole plus lomustine or temozolomide in patients with recurrent glioblastoma: A randomised open-label phase II trial
    Patil, Vijay M.
    Menon, Nandini
    Chatterjee, Abhishek
    Tonse, Raees
    Choudhari, Amit
    Mahajan, Abhishek
    Puranik, Ameya D.
    Epari, Sridhar
    Jadhav, Monica
    Pathak, Shruti
    Peelay, Zoya
    Walavalkar, Rutuja
    Muthuluri, Hemanth K.
    Krishna, Madala Ravi
    Chandrasekharan, Arun
    Pande, Nikhil
    Gupta, Tejpal
    Banavali, Shripad
    Jalali, Rakesh
    ECLINICALMEDICINE, 2022, 49
  • [42] A randomised, open-label phase II trial of afatinib versus cetuximab in patients with metastatic colorectal cancer
    Hickish, Tamas
    Cassidy, Jim
    Propper, David
    Chau, Ian
    Falk, Stephen
    Ford, Hugo
    Iveson, Tim
    Braun, Michael
    Potter, Vanessa
    Macpherson, Iain R.
    Finnigan, Helen
    Lee, Chooi
    Jones, Hilary
    Harrison, Mark
    EUROPEAN JOURNAL OF CANCER, 2014, 50 (18) : 3136 - 3144
  • [43] RITAZAREM: AN INTERNATIONAL, OPEN-LABEL, RANDOMISED CONTROLLED TRIAL COMPARING RITUXIMAB WITH AZATHIOPRINE AS MAINTENANCE THERAPY IN RELAPSING ANCA-ASSOCIATED VASCULITIS
    Smith, Rona Marie
    Arimura, Yoshihiro
    Merkel, Peter A.
    Jayne, David R. W.
    RHEUMATOLOGY, 2017, 56 : 150 - 151
  • [44] A randomized and open-label phase II trial reports the efficacy of neoadjuvant lobaplatin in breast cancer
    Wu, Xiujuan
    Tang, Peng
    Li, Shifei
    Wang, Shushu
    Liang, Yueyang
    Zhong, Ling
    Ren, Lin
    Zhang, Ting
    Zhang, Yi
    NATURE COMMUNICATIONS, 2018, 9
  • [45] A PHASE II, OPEN-LABEL, SINGLE ARM TRIAL OF PEMBROLIZUMAB FOR REFRACTORY ATYPICAL AND ANAPLASTIC MENINGIOMA AND HEMANGIOPERICYTOMA
    Yust-Katz, Shlomit
    Amiel, Alexandra
    Yust-Katz, Shlomit
    Limon, Dror
    NEURO-ONCOLOGY, 2021, 23 : 57 - 57
  • [46] EFFICACY OF BROMOCRIPTINE IN AN OPEN-LABEL THERAPEUTIC TRIAL FOR SYSTEMIC LUPUS-ERYTHEMATOSUS
    MCMURRAY, RW
    WEIDENSAUL, D
    ALLEN, SH
    WALKER, SE
    JOURNAL OF RHEUMATOLOGY, 1995, 22 (11) : 2084 - 2091
  • [47] Efficacy and safety of direct switch to indacaterol/glycopyrronium in patients with moderate COPD: the CRYSTAL open-label randomised trial
    Vogelmeier, Claus F.
    Gaga, Mina
    Aalamian-Mattheis, Maryam
    Greulich, Timm
    Marin, Jose M.
    Castellani, Walter
    Ninane, Vincent
    Lane, Stephen
    Nunez, Xavier
    Patalano, Francesco
    Clemens, Andreas
    Kostikas, Konstantinos
    RESPIRATORY RESEARCH, 2017, 18
  • [48] Safety, pharmacodynamics, and activity of rituximab in patients with relapsing-remitting multiple sclerosis: a phase I, multicentre, open-label clinical trial
    Bar-Or, A.
    Calabresi, P.
    Arnold, D. L.
    Markowitz, C.
    Shafer, S.
    Kasper, L.
    Waubant, E.
    Gazda, S.
    Fox, R.
    Panzara, M.
    Sarkar, N.
    Agarwal, S.
    Smith, C.
    MULTIPLE SCLEROSIS, 2007, 13 : S165 - S166
  • [49] Efficacy and safety of direct switch to indacaterol/glycopyrronium in patients with moderate COPD: the CRYSTAL open-label randomised trial
    Claus F. Vogelmeier
    Mina Gaga
    Maryam Aalamian-Mattheis
    Timm Greulich
    Jose M. Marin
    Walter Castellani
    Vincent Ninane
    Stephen Lane
    Xavier Nunez
    Francesco Patalano
    Andreas Clemens
    Konstantinos Kostikas
    Respiratory Research, 18
  • [50] Teriflunomide efficacy and safety in pediatric patients with relapsing forms of MS: interim analysis of open-label terikids trial extension
    Chitnis, T.
    Banwell, B.
    Arnold, D. L.
    Gucuyener, K.
    Deiva, K.
    Skripchenko, N.
    Cui, L. -Y.
    Saubadu, S.
    Hu, W.
    Benamor, M.
    Le-Halpere, A.
    Truffinet, P.
    Tardieu, M.
    MULTIPLE SCLEROSIS JOURNAL, 2020, 26 (3_SUPPL) : 5 - 6
12345